Tri Locum Partners LP’s Arcturus Therapeutics Hldgs Position
Does Tri Locum Partners LP own Arcturus Therapeutics Hldgs (ARCT)? Not currently — the last reported position was 138.9K shares worth $5M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q1 2024
Shares
138.9K
% of Portfolio
+1.63%
Quarters Held
4
position exited
Position History ARCT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tri Locum Partners LP’s full portfolio or all institutional holders of ARCT.